279 related articles for article (PubMed ID: 18357740)
1. [Preparation of PEG-modified nanostructured lipid carriers loaded with hydroxycamptothecin and tissue distribution in mice].
Zhang XX; Gan Y; Yang XG; Zhu CL; Gan L; Nie SF; Pan WS
Yao Xue Xue Bao; 2008 Jan; 43(1):91-6. PubMed ID: 18357740
[TBL] [Abstract][Full Text] [Related]
2. PEGylated nanostructured lipid carriers loaded with 10-hydroxycamptothecin: an efficient carrier with enhanced anti-tumour effects against lung cancer.
Zhang X; Gan Y; Gan L; Nie S; Pan W
J Pharm Pharmacol; 2008 Aug; 60(8):1077-87. PubMed ID: 18644200
[TBL] [Abstract][Full Text] [Related]
3. Preparation of a dispersible PEGylate nanostructured lipid carriers (NLC) loaded with 10-hydroxycamptothecin by spray-drying.
Zhang X; Pan W; Gan L; Zhu C; Gan Y; Nie S
Chem Pharm Bull (Tokyo); 2008 Dec; 56(12):1645-50. PubMed ID: 19043233
[TBL] [Abstract][Full Text] [Related]
4. Novel anti-tumor strategy: PEG-hydroxycamptothecin conjugate loaded transferrin-PEG-nanoparticles.
Hong M; Zhu S; Jiang Y; Tang G; Sun C; Fang C; Shi B; Pei Y
J Control Release; 2010 Jan; 141(1):22-9. PubMed ID: 19735683
[TBL] [Abstract][Full Text] [Related]
5. Preparation and characterization of 10-hydroxycamptothecin loaded nanostructured lipid carriers.
Liu K; Sun J; Wang Y; He Y; Gao K; He Z
Drug Dev Ind Pharm; 2008 May; 34(5):465-71. PubMed ID: 18473227
[TBL] [Abstract][Full Text] [Related]
6. [9-nitrocamptothecin nanostructured lipid carrier system: in vitro releasing characteristics, uptake by cells, and tissue distribution in vivo].
Li JC; Sha XY; Zhang LJ; Fang XL
Yao Xue Xue Bao; 2005 Nov; 40(11):970-5. PubMed ID: 16499078
[TBL] [Abstract][Full Text] [Related]
7. Preparation, characterization and biodistribution of the lactone form of 10-hydroxycamptothecin (HCPT)-loaded bovine serum albumin (BSA) nanoparticles.
Yang L; Cui F; Cun D; Tao A; Shi K; Lin W
Int J Pharm; 2007 Aug; 340(1-2):163-72. PubMed ID: 17482779
[TBL] [Abstract][Full Text] [Related]
8. Intracellular delivery of 10-hydroxycamptothecin with targeted nanostructured lipid carriers against multidrug resistance.
Liu M; Chen D; Mukerabigwi JF; Chen S; Zhang Y; Lei S; Luo S; Wen Z; Cao Y; Huang X; He H
J Drug Target; 2016; 24(5):433-40. PubMed ID: 26422582
[TBL] [Abstract][Full Text] [Related]
9. Lipid nanoparticles loaded with 10-hydroxycamptothecin-phospholipid complex developed for the treatment of hepatoma in clinical application.
Wei W; Shi SJ; Liu J; Sun X; Ren K; Zhao D; Zhang XN; Zhang ZR; Gong T
J Drug Target; 2010 Aug; 18(7):557-66. PubMed ID: 20131981
[TBL] [Abstract][Full Text] [Related]
10. Effect of octreotide-polyethylene glycol(100) monostearate modification on the pharmacokinetics and cellular uptake of nanostructured lipid carrier loaded with hydroxycamptothecine.
Su Z; Niu J; Xiao Y; Ping Q; Sun M; Huang A; You W; Sang X; Yuan D
Mol Pharm; 2011 Oct; 8(5):1641-51. PubMed ID: 21770405
[TBL] [Abstract][Full Text] [Related]
11. Baicalin-loaded PEGylated lipid nanoparticles: characterization, pharmacokinetics, and protective effects on acute myocardial ischemia in rats.
Zhang S; Wang J; Pan J
Drug Deliv; 2016 Nov; 23(9):3696-3703. PubMed ID: 27749105
[TBL] [Abstract][Full Text] [Related]
12. Hydroxycamptothecin-loaded nanoparticles enhance target drug delivery and anticancer effect.
Wang A; Li S
BMC Biotechnol; 2008 May; 8():46. PubMed ID: 18454874
[TBL] [Abstract][Full Text] [Related]
13. 10-Hydroxycamptothecin (HCPT) nanosuspensions stabilized by mPEG
Yang L; Hong J; Di J; Guo Y; Han M; Liu M; Wang X
Int J Nanomedicine; 2017; 12():3681-3695. PubMed ID: 28553107
[TBL] [Abstract][Full Text] [Related]
14. Novel PEG-grafted nanostructured lipid carrier for systematic delivery of a poorly soluble anti-leukemia agent Tamibarotene: characterization and evaluation.
Liu X; Zhang Z; Jiang Y; Hu Y; Wang Z; Liu J; Feng R; Zhang J; Huang G
Drug Deliv; 2015 Feb; 22(2):223-9. PubMed ID: 24559497
[TBL] [Abstract][Full Text] [Related]
15. [Distribution of hydroxycamptothecin after aerosol inhalation in rabbits].
Chen J; Fang Y; Zhang HX; Huang LL; Qian XP; Liu BR
Yao Xue Xue Bao; 2004 Sep; 39(9):747-51. PubMed ID: 15606028
[TBL] [Abstract][Full Text] [Related]
16. Preparation of 10-hydroxycamptothecin-loaded glycyrrhizic acid-conjugated bovine serum albumin nanoparticles for hepatocellular carcinoma-targeted drug delivery.
Zu Y; Meng L; Zhao X; Ge Y; Yu X; Zhang Y; Deng Y
Int J Nanomedicine; 2013; 8():1207-22. PubMed ID: 23569373
[TBL] [Abstract][Full Text] [Related]
17. Intracellular target delivery of 10-hydroxycamptothecin with solid lipid nanoparticles against multidrug resistance.
Liu M; Chen D; Wang C; Chen X; Wen Z; Cao Y; He H
J Drug Target; 2015; 23(9):800-5. PubMed ID: 25766079
[TBL] [Abstract][Full Text] [Related]
18. Preparation and
Zhou T; Tang X; Zhang W; Feng J; Wu W
Drug Deliv; 2019 Dec; 26(1):673-679. PubMed ID: 31266376
[TBL] [Abstract][Full Text] [Related]
19. Preparation, Characterization, and in vivo Evaluation of NK4-Conjugated Hydroxycamptothecin-Loaded Liposomes.
Zhou T; Zhang W; Cheng D; Tang X; Feng J; Wu W
Int J Nanomedicine; 2020; 15():2277-2286. PubMed ID: 32280220
[TBL] [Abstract][Full Text] [Related]
20. [Preparation and in vitro drug release study of long-circulating hydroxycamptothecin nanoparticles].
Xi N; Hou LB
Zhong Yao Cai; 2010 Apr; 33(4):610-3. PubMed ID: 20845792
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
